To view digital features for this article go to Introduction Type 2 diabetes (T2D) is a progressive, chronic, metabolic disease characterised by persistent hyperglycaemia which, if left untreated, is associated with increased risk of long-term microvascular and macrovascular complications [1]
A major study from March 2025 involving 350,000 individuals found that patients taking Ozempic for two years faced more than double the risk of developing NAION compared to those using other type 2 diabetes treatments
Methods Reagents and animals Male C57BL/6J mice, aged 4 weeks and weighing approximately 1820 g, were obtained from Beijing Vital River Laboratory Animal Technology
A prespecified analysis of SELECT examined 4,286 participants (24.3% of the total trial population) who had investigator-defined heart failure at enrollment
Sometimes, it's too much, which leads to nausea, vomiting or constipation." How common are constipation, diarrhea and nausea when taking Ozempic
falsely advertised its compounded GLP-1 injections as containing the same active ingredient as brand-name weight loss drugs Ozempic and Wegovy, despite differences in formulation and regulatory status
